|
US2021106664A1
|
|
Alpha-lactalbumin vaccination for inhibiting growth and development of male breast cancers
|
|
US2021079357A1
|
|
Generating human podocyte cells
|
|
US2021069205A1
|
|
Bace1 inhibition for the treatment of cancer
|
|
US2021032698A1
|
|
Hsd3b1 gene and 3beta-hsd1 protein variant detection for determining corticosteroid responsiveness
|
|
WO2021007570A1
|
|
System and method for model-based stent design and placement
|
|
US2020402232A1
|
|
Automated identification of acute aortic syndromes in computed tomography images
|
|
WO2020243390A1
|
|
Functionalized fullerene gel tumor treatment
|
|
WO2020237141A1
|
|
Generating dorsal foregut, and anterior domain, endoderm cells
|
|
WO2020242983A1
|
|
Timed administration of decitabine and 5-azacytidine for cancer treatment
|
|
WO2020232086A1
|
|
Induced human colitic organoids
|
|
WO2020227703A1
|
|
Adaptive psychological assessment tool
|
|
US2020346010A1
|
|
Intra-oral appliances and systems
|
|
WO2020219720A1
|
|
Allosteric activators of the alpha1a -adrenergic receptor
|
|
WO2020219483A1
|
|
Thrombolytic and neuro/vasculoprotective nanoconjugates
|
|
US2020282017A1
|
|
Compositions and method for reducing virulence of microorganisms
|
|
WO2020168126A1
|
|
Vaccine adjuvants and formulations
|
|
WO2020163552A1
|
|
Non-invasive method for diagnosing hepatocellular carcinoma
|
|
US2020155062A1
|
|
Monitoring the effects of therapeutics on the brain via gene expression and brain imaging
|
|
US2020146608A1
|
|
Standardized measurement of physiological pressures using an air-charged catheter apparatus
|
|
US2020229914A1
|
|
Methods of treating airway stenosis
|
